Literature DB >> 6130649

Phosphonoacetic acid-resistant RNA of Epstein-Barr virus in productively infected cells.

S Shin, J Donovan, M Nonoyama.   

Abstract

The transcription of Epstein-Barr virus genome in productively infected B95-8 cells in the presence or absence of phosphonoacetic acid (PAA) was studied. Twenty-eight species of cytoplasmic poly(A)-containing virus mRNA were identified as PAA resistant. Some of these viral mRNAs were not detected in the absence of PAA. The most actively transcribed fragments of cloned EBV DNA in the presence of PAA were BamHI H (map unit 29.1-32.5) and M (47.3-50.3). The treatment of TPA-induced B95-8 cells with cycloheximide abolished most cytoplasmic viral poly(A) RNAs, and only three species of viral mRNA (0.7, 1.0, and 1.6 megadaltons) were detectable by hybridization with the BamHI M fragment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130649     DOI: 10.1016/0042-6822(83)90306-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells.

Authors:  C X Zhang; G Decaussin; J Daillie; T Ooka
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

2.  Accelerated onset of viral transcription in adenovirus-infected HeLa cells treated with the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate.

Authors:  T H Carter; Z Z Milovanovic; L E Babiss; P B Fisher
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

3.  Construction and use of cDNA clones for the mapping and identification of Epstein-Barr virus early P3HR-1 mRNAs.

Authors:  E Manet; A Chevallier; C X Zhang; T Ooka; P Chavrier; J Daillie
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Mapping of genes in BamHI fragment M of Epstein-Barr virus DNA that may determine the fate of viral infection.

Authors:  J Sample; G Lancz; M Nonoyama
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.